The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
about
The effect of chemotherapy-induced anemia on dose reduction and dose delay.Real-world impact of granulocyte-colony stimulating factor on febrile neutropeniaNeutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practiceCost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin LymphomaThe use of granulocyte colony-stimulating factors in a Canadian outpatient setting.Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis.Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinatiA Phase IV Clinical Trial of Patients with Solid Tumors Receiving Lenograstim as Primary Prophylaxis for Chemotherapy-Induced Neutropenia, in a Docetaxel-Based Regimen
P2860
Q33432161-E9FC9E7C-2604-42CD-B949-F757F88D0406Q36897773-6E1B9AF3-A8C3-4CEB-ACA4-518880FD6490Q37554901-28EC2180-48EA-4490-9CF5-E26858BE6C48Q37710149-837E47B5-3EB3-4CF3-82AA-62D4938C7C98Q37719624-6885A905-83AE-4512-A3E7-E2AB7E16B132Q37976586-92D31B94-9E18-4A30-91B1-C4C8F6B207C7Q58700818-8A95EAF0-2CC9-4F56-889C-1B8C79C80F76Q59050832-845B2EB5-03C2-40FC-A052-CA40595E6B67
P2860
The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@ast
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@en
type
label
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@ast
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@en
prefLabel
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@ast
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@en
P2093
P2860
P356
P1433
P1476
The use of chemotherapy regime ...... er and non-Hodgkin's lymphoma.
@en
P2093
Ahmad Awada
André Bosly
Christian Focan
Didier Verhoeven
Greet Bries
Jean-Pascal Machiels
Jeroen Mebis
Laetitia Gerlier
Luc Somers
Mark Lamotte
P2860
P2888
P356
10.1186/1471-2407-10-642
P407
P577
2010-11-23T00:00:00Z
P5875
P6179
1042524632